Lawsuit Accuses Wyeth of Monopoly through Illegal Patents in California
A New York-based retail pharmacy has filed a federal lawsuit that alleges pharmaceutical company Wyeth profited immensely by misrepresenting clinical data to retain a monopoly over a highly popular drug used to treat psychiatric conditions. Unveiling Allegations: How Wyeth Allegedly Extended Its Effexor Monopoly The lawsuit has been filed by Uniondale Chemists Inc. in the […]
Read More →